Company Data
NRX Pharmaceuticals Inc.
Ticker
NRXP
Current Price
$4.62
Market Cap
$167.4M
Price Target
Refer to Report
Volume
2.0M
52wk Range
$1.62 - $4.86
Overview
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.